Inspire Medical Systems, Inc. (INSP)

$135.05

-4.55

(-3.26%)▲

Market is closed - opens 7 PM, 26 Jul 2024

Performance

  • $135.05
    $140.23
    $135.05
    downward going graph

    0.0%

    Downside

    Day's Volatility :3.69%

    Upside

    3.69%

    downward going graph
  • $123.27
    $293.63
    $135.05
    downward going graph

    8.72%

    Downside

    52 Weeks Volatility :58.02%

    Upside

    54.01%

    downward going graph

Returns

PeriodInspire Medical Systems, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-43.12%
6.5%
0.0%
6 Months
-36.54%
7.1%
0.0%
1 Year
-52.92%
9.8%
0.0%
3 Years
-22.27%
14.2%
-20.2%

Highlights

Market Capitalization
4.1B
Book Value
$19.85
Earnings Per Share (EPS)
-0.53
Wall Street Target Price
230.19
Profit Margin
-2.38%
Operating Margin TTM
-9.28%
Return On Assets TTM
-3.58%
Return On Equity TTM
-2.88%
Revenue TTM
660.9M
Revenue Per Share TTM
22.45
Quarterly Revenue Growth YOY
28.199999999999996%
Gross Profit TTM
341.7M
EBITDA
-32.9M
Diluted Eps TTM
-0.53
Quarterly Earnings Growth YOY
3.68
EPS Estimate Current Year
0.16
EPS Estimate Next Year
0.88
EPS Estimate Current Quarter
-0.65
EPS Estimate Next Quarter
-0.23

Analyst Recommendation

Buy
    72%Buy
    28%Hold
    0
    0%Sell
Based on 25 Wall street analysts offering stock ratings for Inspire Medical Systems, Inc.(by analysts ranked 0 to 5 stars)
Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
17
15
Hold
7
7
7
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 70.45%

Current $135.05
Target $230.19

Company Financials

FY18Y/Y Change
Revenue
50.6M
↑ 77.1%
Net Income
-21.8M
↑ 24.65%
Net Profit Margin
-43.14%
↑ 18.16%
FY19Y/Y Change
Revenue
82.1M
↑ 62.18%
Net Income
-33.2M
↑ 52.3%
Net Profit Margin
-40.52%
↑ 2.62%
FY20Y/Y Change
Revenue
115.4M
↑ 40.62%
Net Income
-57.2M
↑ 72.08%
Net Profit Margin
-49.58%
↓ 9.06%
FY21Y/Y Change
Revenue
233.4M
↑ 102.28%
Net Income
-42.0M
↓ 26.5%
Net Profit Margin
-18.01%
↑ 31.57%
FY22Y/Y Change
Revenue
407.9M
↑ 74.75%
Net Income
-44.9M
↑ 6.75%
Net Profit Margin
-11.0%
↑ 7.01%
FY23Y/Y Change
Revenue
624.8M
↑ 53.19%
Net Income
-21.2M
↓ 52.87%
Net Profit Margin
-3.39%
↑ 7.61%
Q4 FY22Q/Q Change
Revenue
137.9M
↑ 26.3%
Net Income
3.2M
↓ 118.7%
Net Profit Margin
2.28%
↑ 17.71%
Q1 FY23Q/Q Change
Revenue
127.9M
↓ 7.25%
Net Income
-15.4M
↓ 589.65%
Net Profit Margin
-12.06%
↓ 14.34%
Q2 FY23Q/Q Change
Revenue
151.1M
↑ 18.14%
Net Income
-12.0M
↓ 22.51%
Net Profit Margin
-7.91%
↑ 4.15%
Q3 FY23Q/Q Change
Revenue
153.3M
↑ 1.46%
Net Income
-8.5M
↓ 28.55%
Net Profit Margin
-5.57%
↑ 2.34%
Q4 FY23Q/Q Change
Revenue
192.5M
↑ 25.57%
Net Income
14.8M
↓ 272.87%
Net Profit Margin
7.67%
↑ 13.24%
Q1 FY24Q/Q Change
Revenue
164.0M
↓ 14.8%
Net Income
-10.0M
↓ 167.77%
Net Profit Margin
-6.1%
↓ 13.77%
FY18Y/Y Change
Total Assets
200.1M
↑ 697.42%
Total Liabilities
36.1M
↑ 52.84%
FY19Y/Y Change
Total Assets
181.3M
↓ 9.41%
Total Liabilities
41.4M
↑ 14.79%
FY20Y/Y Change
Total Assets
281.2M
↑ 55.14%
Total Liabilities
51.4M
↑ 24.2%
FY21Y/Y Change
Total Assets
295.1M
↑ 4.94%
Total Liabilities
66.0M
↑ 28.37%
FY22Y/Y Change
Total Assets
564.9M
↑ 91.43%
Total Liabilities
68.9M
↑ 4.29%
FY23Y/Y Change
Total Assets
676.8M
↑ 19.82%
Total Liabilities
104.3M
↑ 51.44%
Q4 FY22Q/Q Change
Total Assets
564.9M
↑ 7.08%
Total Liabilities
68.9M
↑ 20.15%
Q1 FY23Q/Q Change
Total Assets
571.8M
↑ 1.23%
Total Liabilities
67.2M
↓ 2.42%
Q2 FY23Q/Q Change
Total Assets
618.2M
↑ 8.11%
Total Liabilities
88.9M
↑ 32.27%
Q3 FY23Q/Q Change
Total Assets
639.5M
↑ 3.44%
Total Liabilities
95.3M
↑ 7.23%
Q4 FY23Q/Q Change
Total Assets
676.8M
↑ 5.84%
Total Liabilities
104.3M
↑ 9.42%
Q1 FY24Q/Q Change
Total Assets
685.8M
↑ 1.33%
Total Liabilities
96.8M
↓ 7.17%
FY18Y/Y Change
Operating Cash Flow
-18.7M
↑ 18.38%
Investing Cash Flow
-83.4M
↑ 997.22%
Financing Cash Flow
190.4M
↑ 641.92%
FY19Y/Y Change
Operating Cash Flow
-32.8M
↑ 75.7%
Investing Cash Flow
-43.6M
↓ 47.76%
Financing Cash Flow
2.0M
↓ 98.97%
FY20Y/Y Change
Operating Cash Flow
-53.0M
↑ 61.5%
Investing Cash Flow
86.6M
↓ 298.87%
Financing Cash Flow
134.1M
↑ 6726.12%
FY21Y/Y Change
Operating Cash Flow
-20.1M
↓ 62.07%
Investing Cash Flow
29.1M
↓ 66.36%
Financing Cash Flow
14.9M
↓ 88.85%
FY22Y/Y Change
Operating Cash Flow
11.6M
↓ 157.5%
Investing Cash Flow
-19.6M
↓ 167.25%
Financing Cash Flow
235.1M
↑ 1472.63%
Q4 FY22Q/Q Change
Operating Cash Flow
19.3M
↑ 75.14%
Investing Cash Flow
-3.0M
↓ 21.58%
Financing Cash Flow
7.3M
↓ 96.75%
Q1 FY23Q/Q Change
Operating Cash Flow
-1.3M
↓ 106.97%
Investing Cash Flow
-3.8M
↑ 27.22%
Financing Cash Flow
5.6M
↓ 22.75%
Q2 FY23Q/Q Change
Operating Cash Flow
5.1M
↓ 478.87%
Investing Cash Flow
4.9M
↓ 230.43%
Financing Cash Flow
14.9M
↑ 165.21%
Q3 FY23Q/Q Change
Operating Cash Flow
3.6M
↓ 28.55%
Investing Cash Flow
-144.2M
↓ 3046.7%
Financing Cash Flow
3.5M
↓ 76.56%

Technicals Summary

Sell

Neutral

Buy

Inspire Medical Systems, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.
-2.07%
-36.54%
-52.92%
-22.27%
99.19%
Stryker Corporation
Stryker Corporation
-3.84%
5.16%
12.86%
24.25%
52.69%
Boston Scientific Corp.
Boston Scientific Corp.
-3.68%
21.48%
41.72%
68.89%
76.47%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-34.8%
-18.49%
-34.85%
-45.17%
-15.86%
Abbott Laboratories
Abbott Laboratories
1.03%
-5.4%
-7.12%
-11.35%
20.75%
Medtronic Plc
Medtronic Plc
-1.99%
-9.34%
-13.21%
-38.74%
-23.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.
NA
NA
NA
0.16
-0.03
-0.04
NA
19.85
Stryker Corporation
Stryker Corporation
38.91
38.91
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.22
63.22
1.8
2.37
0.09
0.05
NA
13.16
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
36.4
36.4
5.19
2.76
0.22
0.12
NA
12.35
Abbott Laboratories
Abbott Laboratories
33.84
33.84
5.99
4.66
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
28.97
28.97
1.52
5.2
0.07
0.04
0.04
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.
Buy
$4.1B
99.19%
NA
-2.38%
Stryker Corporation
Stryker Corporation
Buy
$129.7B
52.69%
38.91
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$114.3B
76.47%
63.22
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.4B
-15.86%
36.4
23.74%
Abbott Laboratories
Abbott Laboratories
Buy
$186.6B
20.75%
33.84
13.65%
Medtronic Plc
Medtronic Plc
Buy
$102.5B
-23.49%
28.97
11.36%

Insights on Inspire Medical Systems, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 192.50M → 164.01M (in $), with an average decrease of 14.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 14.76M → -10.00M (in $), with an average decrease of 167.8% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 41.7% return, outperforming this stock by 94.6%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 68.9% return, outperforming this stock by 91.2%

Institutional Holdings

  • FMR Inc

    14.94%

  • Vanguard Group Inc

    9.74%

  • Wellington Management Company LLP

    6.57%

  • BlackRock Inc

    6.36%

  • Baillie Gifford & Co Limited.

    4.94%

  • Wasatch Advisors LP

    3.71%

Corporate Announcements

  • Inspire Medical Systems, Inc. Earnings

    Inspire Medical Systems, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

inspire medical systems, inc. is a medical devices company based out of 9700 63rd avenue north suite 200, maple grove, minnesota, united states.

Organization
Inspire Medical Systems, Inc.
Employees
1011
CEO
Mr. Timothy P. Herbert
Industry
Health Technology

Discover More

FAQs